Evidence map›Paper›PMID 20195476›Full record

ArticlePloS one2010

Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.

Ali S Arbab, Branislava Janic, Kourosh Jafari-Khouzani, A S M Iskander, Sanath Kumar, Nadimpalli R S Varma, Robert A Knight, Hamid Soltanian-Zadeh, Stephen L Brown, Joseph A Frank

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ali S ArbabCellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, Michigan, United States of America. saali@rad.hfh.edu
Branislava Janic
Kourosh Jafari-Khouzani
A S M Iskander
Sanath Kumar
Nadimpalli R S Varma
Robert A Knight
Hamid Soltanian-Zadeh
Stephen L Brown
Joseph A Frank
Henry Ford Hospital · USNational Institutes of Health Clinical Center · US

Funding

Cellular MRI in Glioma and Radiation NecrosisR01CA122031 · NCI · HENRY FORD HEALTH SYSTEM · PI ARBAB, ALI SYED · 2007 to 2010
$992k
Stem Cells as Delivery Vehicles and Imaging Probes for Glioma Gene TherapyR21CA129801 · NCI · HENRY FORD HEALTH SYSTEM · PI ARBAB, ALI SYED · 2008 to 2009
$359k
Differentiation of Glioma from Radiation Injury Using Cellular MRIR21NS058589 · NINDS · HENRY FORD HEALTH SYSTEM · PI ARBAB, ALI SYED · 2007 to 2008
$349k
Pre-clinical evaluation of Magnetically labeled Cells for Cellular MRIZIACL090007 · CLC · CLINICAL CENTER · PI FRANK, JOSEPH · 2009 to 2018
$0k
Intramural NIH HHS ZIA CL090007NCI NIH HHS 1R21CA129801NCI NIH HHS R01 CA122031NCI NIH HHS R01CA122031NCI NIH HHS R21 CA129801NINDS NIH HHS R21 NS058589NINDS NIH HHS R21NS058589
6 · The paper itself

Abstract

backgroundA limitation with current imaging strategies of recurrent glioma undergoing radiotherapy is that tumor and radiation injury cannot be differentiated with post contrast CT or MRI, or with PET or other more complex parametric analyses of MRI data. We propose to address the imaging limitation building on emerging evidence indicating that effective therapy for recurrent glioma can be attained by sensitized T-cells following vaccination of primed dendritic cells (DCs). The purpose of this study was to determine whether cord blood T-cells can be sensitized against glioma cells (U-251) and if these sensitized cytotoxic T-cells (CTLs) can be used as cellular magnetic resonance imaging probes to identify and differentiate glioma from radiation necrosis in rodent models. METHODOLOGY/PRINCIPAL

findingsCord blood T and CD14+ cells were collected. Isolated CD14+ cells were then converted to dendritic cells (DCs), primed with glioma cell lysate and used to sensitize T-cells. Phenotypical expression of the generated DCs were analyzed to determine the expression level of CD14, CD86, CD83 and HLA-DR. Cells positive for CD25, CD4, CD8 were determined in generated CTLs. Specificity of cytotoxicity of the generated CTLs was also determined by lactate dehydrogenase (LDH) release assay. Secondary proliferation capacity of magnetically labeled and unlabeled CTLs was also determined. Generated CTLs were magnetically labeled and intravenously injected into glioma bearing animals that underwent MRI on days 3 and 7 post- injection. CTLs were also administered to animals with focal radiation injury to determine whether these CTLs accumulated non-specifically to the injury sites. Multi-echo T2- and T2*-weighted images were acquired and R2 and R2* maps created. Our method produced functional, sensitized CTLs that specifically induced U251 cell death in vitro. Both labeled and unlabeled CTLs proliferated equally after the secondary stimulation. There were significantly higher CD25 positive cells (p = <0.006) in CTLs. In addition, T2- and T2*-weighted MR images showed increased low signal intensity areas in animals that received labeled CTLs as compared to the images from animals that received control cells. Histological analysis confirmed the presence of iron positive cells in sites corresponding to MRI low signal intensity regions. Significant differences (p = <0.001) in tumor R2 and R2* values were observed among the groups of animals. Animals with radiation injury exhibited neither MRI hypointense areas nor presence of iron positive cells.

conclusionOur results indicate that T-cells can be effectively sensitized by in vitro methods and used as cellular probes to identify and differentiate glioma from radiation necrosis.

Indexed as

AnimalsBrain NeoplasmsCD4 AntigensCD8 AntigensCell Line, TumorDendritic CellsDiagnosis, DifferentialFetal BloodGliomaHumansImmunotherapy, AdoptiveInterleukin-2 Receptor alpha SubunitMagnetic Resonance ImagingMagneticsNeoplasmsNeoplasms, Radiation-InducedCD4 AntigensCD8 AntigensInterleukin-2 Receptor alpha Subunit

Identifiers

PMID20195476
PMCPMC2829084
OpenAlexW2084314225

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.